Filing Details
- Accession Number:
- 0001209191-14-037251
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-27 19:41:18
- Reporting Period:
- 2014-05-14
- Filing Date:
- 2014-05-27
- Accepted Time:
- 2014-05-27 19:41:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1130591 | Xenoport Inc | XNPT | Pharmaceutical Preparations (2834) | 943330837 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296771 | Gordon John Freund | 525 University Avenue, Ste. 520 C/O Skyline Ventures Palo Alto CA 94301 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-14 | 5,000 | $0.00 | 8,899 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-05-22 | 5,500 | $3.75 | 11,700 | No | 4 | P | Indirect | Beneficial Ownership |
Common Stock | Acquisiton | 2014-05-23 | 9,500 | $3.72 | 21,200 | No | 4 | P | Indirect | Beneficial Ownership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | P | Indirect | Beneficial Ownership |
No | 4 | P | Indirect | Beneficial Ownership |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-employee director stock unit | Disposition | 2014-05-14 | 5,000 | $0.00 | 5,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 489,469 | Indirect | Through Fund |
Common Stock | 10,133 | Indirect | Beneficial Ownership |
Common Stock | 3,645 | Indirect | Beneficial Ownership |
Common Stock | 3,080 | Indirect | Beneficial Ownership |
Common Stock | 27 | Indirect | Beneficial Ownership |
Footnotes
- 5,000 shares previously owned directly were contributed to Skyline Venture Partners V, L.P. John G. Freund is connected to Skyline Venture Partners V, L.P. as managing director or managing member either directly or through indirect ownership and in such capacity may be deemed to have voting and investment power with respect to shares held by this entity. John G. Freund disclaims beneficial ownership of such securities, except to the extent of his proportionate partnership interest therin.
- The shares are owned by a revocable trust of which John G. Freund is a trustee.
- These shares are held by multiple entities. 22 shares are held by Skyline Venture Partners III, L.P., 887 shares are held by Skyline Venture Partners Qualified Purchasers Fund III, L.P., 227 shares are held by Skyline Venture Management III, L.L.C. and 488,333 shares are held by Skyline Venture Partners V, L.P. John G. Freund is connected to each of these entities as managing director or managing member either directly or through indirect ownership and in such capacity may be deemed to have voting and investment power with respect to shares held by each of these entities. John G. Freund disclaims beneficial ownership of such securities, except to the extent of his proportionate partnership interest therin.
- The shares are owned by a retirement account of which John G. Freund is the beneficiary.
- The shares are held by the Paul Brooke 1989 Insurance Trust of which John G. Freund is a trustee.
- The shares are held by John G. Freund as custodian for his two sons.
- The shares are held by John G. Freund Family Partnership IV, L.P. John G. Freund disclaims beneficial ownership of such securities, except to the extent of his proportionate partnership interest therin.
- Each restricted stock unit represents a contingent right to receive one share of XenoPort, Inc. common stock.
- The restricted stock units shall cliff vest in full on the one-year anniversary of the grant date, May 14, 2013.